Mehrotra R
UCLA School of Medicine, USA.
Adv Perit Dial. 2000;16:67-72.
End-stage renal disease remains the primary indication for the use of peritoneal dialysis. The therapy, however, has been used for the treatment of various other clinical conditions. Evidence has accumulated to support the use of peritoneal dialysis to maintain euvolemia, to improve functional status, and to reduce hospitalizations in patients with intractable chronic congestive heart failure. The use of peritoneal dialysis as a modality for core rewarming in patients with severe hypothermia has been established; in selected circumstances, it is probably the therapy of choice. The field of oncology has borrowed heavily from the technique of peritoneal dialysis for administering intraperitoneal chemotherapy; even though the therapy remains largely experimental today, it has great future potential. While efficacious in the treatment of acute, diuretic-resistant volume overload in patients with congestive heart failure and in patients with severe, disabling psoriasis, the introduction of alternative methods of management have rendered the use of peritoneal dialysis obsolete. Finally, the role of peritoneal lavage in the management of patients with pancreatitis remains controversial and is no longer routinely used.
终末期肾病仍然是使用腹膜透析的主要指征。然而,该疗法也已被用于治疗各种其他临床病症。已有证据支持使用腹膜透析来维持血容量正常、改善功能状态以及减少顽固性慢性充血性心力衰竭患者的住院次数。腹膜透析作为严重低温患者核心复温方式的应用已得到确立;在特定情况下,它可能是首选治疗方法。肿瘤学领域大量借鉴了腹膜透析技术来进行腹腔内化疗;尽管目前该疗法在很大程度上仍处于实验阶段,但具有巨大的未来潜力。虽然腹膜透析在治疗充血性心力衰竭患者的急性、利尿剂抵抗性容量超负荷以及严重、致残性银屑病患者方面有效,但替代管理方法的引入已使腹膜透析的使用过时。最后,腹膜灌洗在胰腺炎患者管理中的作用仍存在争议,且不再常规使用。